Large-scale testing (Phase 3)Study completedNCT04938830
What this trial is testing
Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)
Who this might be right for
RSV Infection
Merck Sharp & Dohme LLC 1,003